HALO logo
halo search icon
Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited
NEU · ASX

Neuren Pharmaceuticals Limited

AU$14.40

Price Arrow0.60 (4.35%)
29/05/2026 03:00:24 PM
All-CompaniesAll-ConsensusConsensus CheapDefying GravityFakey Shakey - Short (Realtime)GROWTH AUSHALO 200HALO Balance Sheet+5
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Neuren Pharmaceuticals Limited Overview

NEU Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Very Weak

Mqv Small

Weak

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About NEU

icon

Telephone

61.3.9092.0480

icon

Address

Hawthorn East, Suite 1.01, 117 Camberwell Road, Melbourne, Victoria (VIC) 3123

Description

Neuren Pharmaceuticals Ltd. engages in the development of new therapies for neurodevelopmental disorders that emerge in early childhood. It operates through the Commercial Products, and Research and Development segments. The Commercial Products segment refers to the milestone and royalty revenue from license of intellectual property. The Research and Development segment focuses on the development of pharmaceutical products for the treatment of neurodevelopmental disorders. The company was founded on December 17, 2001 and is headquartered in Camberwell, Australia.

NEU Price Chart

Key Stats

Market Cap

AU$1.75B

PE

78.40

EV/EBITDA

97

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 11 - 22.99

Trade Value (12mth)

AU$1,868,738.00

1 week

0.95%

1 month

12.47%

YTD

-27.02%

1 year

-2.34%

All time high

25.95

Key Fundamentals

EPS 3 yr Growth

15720.00%

EBITDA Margin

34.10%

Operating Cashflow

$125m

Free Cash Flow Return

35.70%

ROIC

8.70%

Interest Coverage

0.00

Quick Ratio

76.60

Other Data

Shares Outstanding (Fully Diluted)

133m

HALO Sector

Healthcare

Next Company Report Date

24-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

6.16

NEU Announcements

Latest Announcements

DateAnnouncements
27 May 26
27 May 26
14 May 26
12 May 26
12 May 26

NEU Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock1.241.110.24locklocklock
EPS (Fully Diluted)
$locklocklocklock1.21.090.23locklocklock
Growth
%locklocklocklock82,313.3-10.1-78.7locklocklock
PE
Xlocklocklocklock20.211.278.4locklocklock
EV/EBITDA
Xlocklocklocklock15.2897locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

6.16%

Value ($M)

106

Prior Change

0

7 Day Change

-0.10%

1 Month Change

0.30%

3 Months Change

0.80%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NEU Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The current share price of Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$14.40.
What is the 52-week high share price for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The 52-week high share price for Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$22.99.
What is the 52-week low share price for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The 52-week low share price for Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$11.00.
What is the dividend yield for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) does not pay a dividend.
What was Neuren Pharmaceuticals Limited (NEU:ASX) last dividend payment?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) does not pay a dividend.
What is the franking level for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) has a franking level of 0.00%.
In which sector is Neuren Pharmaceuticals Limited (NEU:ASX) classified?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The current P/E ratio for Neuren Pharmaceuticals Limited (NEU:ASX) is 78.40.

See beyond the curve.

One solution for research, investing and portfolio management.